Venue: Munich

Location: Munich, Germany

Event Date/Time: Oct 25, 2011 End Date/Time: Oct 27, 2011
Report as Spam


Incorporating PGx strategies into drug development is becoming the norm.
And considering the potential benefits of using pharmacogenomics, this does not come as a surprise. With increasing regulatory, time and cost pressures – PGx offers great improvements in candidate selection, toxicity assessment and clinical development.
The 2nd World Pharmacogenomics Summit is your chance to update your knowledge and understanding of how to implement a robust PGx strategy. As well as getting a detailed insight into the most exciting research happening in the field right now, you can network and exchange ideas with the leaders in the industry.
Past Hanson Wade feedback:
“One of the best meetings I’ve attended. Outstanding!”
Director, Merck
“An eye-opening and extremely valuable experience, especially for those new to the field”

What will be discussed?

This meeting is specifically designed to help you smooth candidate transition through pre-clinic stages as well as improve clinical development and patient safety. Attend the World PGx Summit to find out about the latest pharmacogenomics developments and to maximise the success of your drug pipeline. You will cover:
• Facilitating candidate selection and investment decisions
• Incorporating a pharmacogenomic strategy in the drug development process
• Bridging the gap from pre-clinical to clinical research
• Using toxicogenomics to improve drug safety and reduce attrition
• Improving clinical success by stratifying patients
• Tackling issues surrounding genomic data handling including sample collection, analysis etc.

Why attend?
Every presentation and contact will help you improve your research and business aims - everyone at the meeting is here to discuss how to associate genomic and molecular data with drug response and how to make the most of molecular data to make better decisions throughout drug development, as well as for patient stratification.
Don't just listen to speakers and attendees - meet them and discuss your work in our intimate and informal conference setting. Plus, we'll make sure you meet everybody you want to in our dedicated speed networking session.
Receive tailored guidance on achieving patient stratification - our pre-conference workshops are a fantastic opportunity to get the information and contacts you need to achieve your research and business aims (over and above the inside information you will gain from the meeting itself).

If you have not been to a Hanson Wade event before, here are a few comments from some of our past delegates to give you an idea of what to expect:

"Outstanding meeting with first class speakers. I learned a lot and I will certainly recommend the meeting to my colleagues..." Director, Head Oncology Business Opportunities, Sanofi Aventis

“Successful in bringing together pharma and diagnostics for information sharing, discussion and networking. Very informative, good representation, great networking.” Abbott Molecular

“That was the best event I have ever attended. I don’t usually consider commercial events but that was very good. You have a committed customer from this point onwards” sanofi aventis

Who's this meeting for?

Whether you are new to the field or expanding your existing capabilities around pharmacogenomics, this meeting is a one-stop shop of the latest developments and strategies you need to be aware of. That means anyone involved with:
• Pharmacogenomics/pharmacogenetics
• Genetics Biomarkers
• Translational medicine
• Clinical pharmacology
• Genetic/molecular toxicology
• Molecular profiling
• Personalized medicine
• (Companion) diagnostics

To register simply:
Call: +44 20 3141 8700

Please quote the booking code: LIST when registering to secure your place at the meeting.